C. Dumke

Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.

A. Schäffer, T. Ried, R. Schwartz, 2014, The American journal of pathology.

Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy

C. Dumke, R. Engenhart-Cabillic, R. Dumke, 2022, Strahlentherapie und Onkologie.

Monocentric evaluation of Ki-67 labeling index in combination with a modified RPA score as a prognostic factor for survival in IDH-wildtype glioblastoma patients treated with radiochemotherapy

C. Dumke, R. Engenhart-Cabillic, R. Dumke, 2022, Strahlentherapie und Onkologie.

Carbon Ion Beam Boost Irradiation in Malignant Tumors of the Nasal Vestibule and the Anterior Nasal Cavity as an Organ-Preserving Therapy

H. Hauswald, B. Stuck, C. Dumke, 2022, Frontiers in Oncology.

SATB1, genomic instability and Gleason grading constitute a novel risk score for prostate cancer

C. Thorns, S. Freitag-Wolf, G. Auer, 2021, Scientific Reports.

Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease

D. Vordermark, H. Hauswald, C. Dumke, 2019, Radiation oncology.

Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy.

H. Hauswald, C. Dumke, R. Engenhart-Cabillic, 2023, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin’s disease

D. Vordermark, H. Hauswald, C. Dumke, 2019, Radiation Oncology.

Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.

A. Schäffer, T. Ried, R. Schwartz, 2014, The American journal of pathology.

PSA outcome after metastasis directed therapy (MDT) of oligometastatic prostate cancer patients diagnosed by 68Ga-PSMA-PET/CT

C. Dumke, R. Engenhart-Cabillic, A. Jensen, 2020 .